Keyword: Enterome Bioscience
The deal gives Takeda a stake in a small molecule designed to disarm virulent bacteria and thereby treat gastrointestinal disorders.
French microbiome biotech Enterome has got off a €32 million ($38.5 million) series D round with the help of some big-name players.
Nestlé Health Science and Enterome have joined forces to create a microbiome-based diagnostics startup.
Bristol-Myers has teamed with Enterome to discover microbiome-derived biomarkers, drug targets and bioactive molecules relevant to its immuno-oncology team.